Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The global contraceptive devices market was valued at USD 12.33 Billion in 2025. It is poised to grow at a CAGR of 6.60% during the forecast period of 2026-2035, and reach USD 23.36 Billion by 2035. The market growth is driven by increasing awareness of family planning, rising demand for effective birth control methods, expanding access to reproductive healthcare services, and growing adoption of long-acting reversible contraceptives and technologically advanced contraceptive devices worldwide.

Latest News on Contraceptive Devices Market (2026)

  • In January 2026, Organon secured FDA approval extending NEXPLANON use to five years, strengthening long-acting contraceptive adoption and reducing replacement visits for patients and providers.
  • In February 2026, Organon licensed global rights to MIUDELLA, expanding hormone-free copper IUD options and strengthening its women’s health portfolio across key contraceptive markets worldwide.
  • In February 2026, NEXT Life Sciences advanced Plan A and NLS-133 into Phase II trials, supporting innovation in non-hormonal male contraception and future product development globally.

Key Market Trends and Insights

  • By product type, the male contraceptive devices segment is likely to dominate the market, holding about 40% market share in the historical period.
  • By distribution channels, retail pharmacies are likely to lead, generating approximately 44% market share in the historical period.
  • By region, Asia Pacific is likely to dominate the market, accounting for about 31% market share in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 12.33 Billion
  • Projected Market Size (2035): USD 23.36 Billion
  • CAGR (2026-2035): 6.60%
  • Largest Market in 2025: Asia Pacific

Compound Annual Growth Rate

6.6%

Value in USD Billion

2026-2035


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Contraceptive Devices Market Overview

The market reached a value of approximately USD 12.33 Billion in 2025. The market is witnessing steady growth due to increasing awareness of family planning, rising demand for effective birth control methods, and expanding access to reproductive healthcare services worldwide. Growing adoption of Long-acting Reversible Contraception (LARC) methods, supported by their high efficacy and extended duration of protection, is significantly contributing to market expansion. Technological advancements in contraceptive devices, favorable healthcare policies, and improved access to reproductive healthcare services are further supporting demand. Additionally, increasing focus on preventing unintended pregnancies and enhancing women's reproductive autonomy is expected to drive sustained market growth.

Contraceptive Devices Market Segmentation

Market Breakup by Product Type

  • Male Contraceptive Devices
    • Condoms
    • Spermicides
  • Female Contraceptive Devices
    • Female Condoms
    • Contraceptive Sponges
    • Contraceptive Vaginal Rings
    • Intrauterine Devices
    • Sub-dermal Contraceptive Implants
    • Non-Surgical Permanent Contraceptive Devices

The market is segmented by product type into male contraceptive devices and female contraceptive devices. Male contraceptive devices include condoms and spermicides, with condoms continuing to see high demand due to easy availability, low cost, and strong awareness. Female contraceptive devices include female condoms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraceptive devices. Demand is supported by rising focus on reproductive health, long-acting contraception, and wider access to family planning products.

Market Breakup by Technology

  • Hormonal Contraceptives
  • Barrier Contraceptives

The market is divided into hormonal contraceptives and barrier contraceptives. Hormonal contraceptives are gaining demand due to their role in long-term pregnancy prevention and use across vaginal rings, implants, and other controlled-release products. Barrier contraceptives continue to hold strong relevance, supported by condom use, protection against sexually transmitted infections, and broad retail availability. Growing awareness of planned parenthood, improved counseling, and product innovation are supporting adoption across these technology categories.

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel
  • Others

The market includes hospital pharmacy, retail pharmacy, online channel, public channel, and others. Retail pharmacies are expected to hold a strong share due to easy product access, repeat purchases, and consumer familiarity with condoms and other contraceptive products. Hospital pharmacies support prescription-based and procedure-linked contraceptive access, especially for implants and intrauterine devices. Online channels are expanding as consumers prefer discreet purchasing, while public channels remain important for government-led family planning programs and broader contraceptive access.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to maintain a strong position due to high awareness, organized healthcare access, and availability of advanced contraceptive options. Europe is supported by favorable reproductive health programs and steady adoption of long-acting devices. Asia Pacific is expected to expand at a faster pace due to a large reproductive-age population, family planning initiatives, and rising healthcare access. Latin America and the Middle East and Africa are also witnessing gradual improvement in contraceptive availability.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Contraceptive Devices Market Growth Analysis and Key Influencers

Analysis Type Factors Example
Market Drivers Long-acting contraception demand and fewer replacement visits support stronger implant adoption and patient convenience worldwide. Organon extended NEXPLANON approval to five years, reducing clinic visits and replacement burden for users.
Market Restraints Provider certification needs and insertion risks may restrict implant availability in low-resource clinical settings nationwide. FDA labeling retained NEXPLANON REMS requirements, requiring certified providers for insertion and removal procedures safely.
Market Opportunities Demand for hormone-free contraception and long-acting methods creates portfolio expansion opportunities across key markets. Organon licensed MIUDELLA globally, strengthening access to hormone-free copper intrauterine device options.

Contraceptive Devices Market Dynamics

This section analyzes key factors influencing market growth, including family planning awareness, reproductive healthcare access, technological advancements in contraceptive devices, regulatory frameworks, consumer preferences, demographic trends, and evolving demand for long-acting and non-hormonal contraception solutions.

Contraceptive Devices Market Drivers

Extended Implant Duration Supports Market Development

Rising demand for long-acting contraception and fewer replacement procedures are supporting market growth in contraceptive devices. For instance, in January 2026, Organon received U.S. FDA approval to extend NEXPLANON use from 3 years to up to 5 years, supported by trial data showing no pregnancies during years 4 and 5. This approval is expected to improve user convenience, reduce clinic visits, and strengthen adoption of implant-based contraception during the forecast period across healthcare settings.

Contraceptive Devices Market Restraints

REMS Requirements Create Access Barriers Restricting Market Avenues

Limited availability of trained providers and procedural safety requirements may create market restraints for contraceptive devices. For instance, in January 2026, FDA labeling for NEXPLANON continued to include a restricted REMS program due to risks linked to improper insertion and removal. This requirement may limit access in some healthcare settings, as providers must complete certification before performing implant procedures. During the forecast period, training needs could slow adoption in areas with fewer qualified professionals.

Contraceptive Devices Market Opportunities

Hormone-Free IUD Licensing Advancing Market Regulation

Growing preference for hormone-free options and wider access to long-acting reversible contraception are supporting market development in contraceptive devices. For instance, in February 2026, Organon entered an agreement to license global rights to MIUDELLA, Sebela Pharmaceuticals’ hormone-free copper intrauterine device. This deal is expected to expand Organon’s reproductive health portfolio, improve commercial availability of newer IUD choices, and support broader adoption among users seeking non-hormonal contraception during the forecast period across key regional healthcare systems and retail channels.

Contraceptive Devices Market Trends

Increasing Male Contraceptive Innovation Supporting Future Market Expansion

Rising interest in shared contraceptive responsibility and demand for non-hormonal male options are shaping market trends in contraceptive devices. For instance, in February 2026, NEXT Life Sciences announced that Plan A and NLS-133 advanced into Phase II clinical trials, including a long-acting male option and a non-hormonal pill. This progress is expected to support product innovation, attract investment, and create new male-focused contraceptive categories during the forecast period as clinical development advances.

Contraceptive Devices Market Share

Retail Pharmacies Likely to Lead the Market Segment by Distribution Channel

The retail pharmacies segment generated approximately 44% market share in the historical period and is likely to lead the market during the forecast period. Its strong position is supported by widespread consumer accessibility, established distribution networks, and growing demand for over-the-counter contraceptive products. Retail outlets continue to play a critical role in improving product availability and convenience for consumers. Increasing awareness of family planning and reproductive healthcare is further supporting demand. The availability of emergency contraceptive devices through retail channels is also contributing to segment growth by improving consumer access, convenience, and timely product availability, particularly in urban and semi-urban markets.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Contraceptive Devices Market Analysis by Region

Asia Pacific accounted for about 31% market share in the historical period and is likely to dominate the market during the forecast period. The region benefits from a large reproductive-age population, expanding healthcare infrastructure, and increasing government initiatives supporting family planning programs. Rising awareness regarding birth control options and improved access to reproductive healthcare services continue to strengthen market demand. Economic development and urbanization are also influencing contraceptive adoption rates. Growing implementation of WHO contraceptive guidelines across healthcare systems is further supporting standardized access and utilization of contraceptive products throughout the region.

Leading Players in the Contraceptive Devices Market

Bayer AG

Bayer AG, headquartered in Leverkusen, Germany, was established in 1863. The company is a global life sciences leader with a strong presence in women’s healthcare. Its contraceptive portfolio includes hormonal intrauterine systems, oral contraceptives, and reproductive health products. Bayer’s extensive research capabilities and global distribution network support its leadership position in the market.

Pfizer Inc.

Pfizer Inc., headquartered in New York, United States, was founded in 1849. The company is a multinational biopharmaceutical organization with a diverse healthcare portfolio. In the contraceptive market, Pfizer offers reproductive health therapies and women’s healthcare products. Its strong research infrastructure, global commercial presence, and focus on innovative healthcare solutions contribute to expanding access to contraception and reproductive health services worldwide.

Janssen Global Services, LLC

Janssen Global Services, LLC, headquartered in Beerse, Belgium, operates as part of Johnson & Johnson, founded in 1886. The company develops pharmaceutical and healthcare solutions across multiple therapeutic areas. Its reproductive health portfolio includes products supporting family planning and women’s health. Through extensive clinical research, strategic collaborations, and global healthcare outreach, Janssen contributes to advancing contraceptive access and reproductive healthcare innovation.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd., headquartered in Tel Aviv, Israel, was established in 1901. The company is one of the world’s largest manufacturers of generic and specialty medicines. Its portfolio includes contraceptive products, women’s health therapies, and reproductive healthcare solutions. Teva’s broad manufacturing capabilities, global distribution network, and commitment to affordable healthcare support its role in expanding contraceptive accessibility across developed and emerging markets.

Other key players in the market include Merck Sharp & Dohme Corp., Mylan N.V., Reckitt Benckiser Group plc., Veru Inc., Medisafe Distribution Inc., CooperSurgical, Inc., Devex, Mayer Laboratories, Inc., Allergan plc., Agile Therapeutics, HLL Lifecare, ANSELL LTD, Mankind Pharma, TTK HealthCare, Boehringer Ingelheim International GmbH., V-Care Pharma Pvt. Ltd., VARDHAMAN LIFECARE PVT LTD, and Cipla Inc.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Key Questions Answered in the Contraceptive Devices Market Report

  • What was the contraceptive devices market value in 2025?
  • What is the contraceptive devices market forecast outlook for 2026-2035?
  • What major factors aid the demand for the contraceptive devices market?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major contraceptive devices market trends?
  • Which product type is expected to dominate the market segment?
  • Which technology is expected to dominate the market segment?
  • Which distribution channel is expected to dominate the market segment?
  • Who are the key players in the contraceptive devices market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

  • Primary Research: Interviews with reproductive health specialists, care providers, pharmacists, payers, and public health stakeholders across key markets.
  • Secondary Research: Regulatory filings, clinical updates, company disclosures, product labels, approval documents, and industry announcements on contraceptive devices.
  • Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling, validated through expert feedback loops.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technology
  • Distribution Channel
  • Region
Breakup by Product Type
  • Male Contraceptive Devices
  • Female Contraceptive Devices
Breakup by Technology
  • Hormonal Contraceptives
  • Barrier Contraceptives
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan N.V.
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
  • CooperSurgical, Inc.
  • Devex
  • Mayer Laboratories, Inc.
  • Allergan plc.
  • Agile Therapeutics
  • HLL Lifecare
  • ANSELL LTD
  • Mankind Pharma
  • TTK HealthCare
  • Boehringer Ingelheim International GmbH.
  • V-Care Pharma Pvt. Ltd.
  • VARDHAMAN LIFECARE PVT LTD
  • Cipla Inc.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us